ALNY

Alnylam Pharmaceuticals, Inc. News Headlines

$96.45
*  
4.37
4.75%
Get ALNY Alerts
*Delayed - data as of Dec. 17, 2014  -  Find a broker to begin trading ALNY now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ALNY Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Alnylam Provides Pipeline Update, Growth Strategy - Analyst Blog
12/15/2014 5:50:00 PM - Zacks.com


Alnylam Provides Pipeline Update, Growth Strategy - Analyst Blog
12/15/2014 5:50:00 AM - Investopedia


Alnylam Pharma Announces Pipeline Growth Strategy For RNAi Therapeutics
12/12/2014 7:18:00 AM - RTT News


Alnylam Pharma To Present At Oppenheimer Conference; Webcast At 2:45 PM ET
12/11/2014 1:45:00 PM - RTT News


Alnylam Reports Positive Initial Phase I Data on ALN-AT3 - Analyst Blog
12/9/2014 5:20:00 PM - Zacks.com


Alnylam Pharmaceuticals (ALNY) Shares March Higher, Can It Continue? - Tale of the Tape
12/9/2014 7:19:18 AM - Zacks.com


Mid-Day Market Update: McDonald's Drops On Weak November Sales; Acceleron Pharma Shares Jump
12/8/2014 12:56:03 PM - Benzinga


Mid-Morning Market Update: Markets Mixed; Merck To Buy Cubist Pharmaceuticals For $102/Share
12/8/2014 10:46:06 AM - Benzinga


Alnylam Pharmaceuticals Inc. (ALNY) Has Broken Out To Over A 10-Month High
12/8/2014 9:59:00 AM - RTT News


Why Alnylam Pharmaceuticals (ALNY) Stock Might be a Great Pick - Tale of the Tape
12/4/2014 8:30:00 AM - Zacks.com


Alnylam Pharma To Present At Deutsche Bank BioFEST; Webcast At 2:15 PM ET
12/2/2014 1:17:00 PM - RTT News


Marina Biotech: A Forgotten And Grossly Undervalued Game-Changer
11/25/2014 10:30:00 AM - Seeking Alpha


Many Sharp Minds Are Invested Long In Tekmira
11/21/2014 1:11:00 PM - Seeking Alpha


Regulus To See Further Declines
11/19/2014 12:21:00 PM - Seeking Alpha


Regulus To See Further Declines
11/19/2014 10:30:00 AM - Seeking Alpha


Regulus To See Further Declines
11/19/2014 10:30:00 AM - SeekingAlpha


Cramer's Lightning Round - Mobileye Will Have A Good Quarter (11/17/14)
11/18/2014 6:40:00 AM - Seeking Alpha


Alnylam Reports Positive Initial Phase II Data on Revusiran - Analyst Blog
11/17/2014 6:40:00 PM - Zacks.com


Alnylam Pharma Announces Positive Initial Phase 2 Data With Revusiran
11/14/2014 6:12:00 AM - RTT News


Alnylam Adds Hepatic Infectious Disease Drugs to Pipeline - Analyst Blog
11/12/2014 5:40:00 PM - Zacks.com


Isis Pharmaceuticals Inc. Strikes Out on Its Own
11/7/2014 2:30:27 PM - Motley Fool


Alnylam Pharmaceuticals Staying Ridiculously Busy
11/7/2014 11:25:00 AM - Seeking Alpha


Alnylam's Q3 Loss Narrower than Expected, Pipeline in Focus - Analyst Blog
11/6/2014 12:40:00 PM - Zacks.com


Investing in Socially Responsible Companies: Alnylam Pharmaceuticals, Inc.
11/6/2014 10:22:02 AM - Motley Fool


Alnylam Pharmaceuticals, Inc. Has This Ratio Right
11/5/2014 8:33:39 PM - Motley Fool